Moderna
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
CEOStéphane Bancel
CEOStéphane Bancel
Employees5,800
Employees5,800
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2010
Founded2010
Employees5,800
Employees5,800
MRNA Key Statistics
Market cap9.86B
Market cap9.86B
Price-Earnings ratio-2.95
Price-Earnings ratio-2.95
Dividend yield—
Dividend yield—
Average volume10.67M
Average volume10.67M
High today$25.85
High today$25.85
Low today$25.08
Low today$25.08
Open price$25.60
Open price$25.60
Volume2.62M
Volume2.62M
52 Week high$170.47
52 Week high$170.47
52 Week low$23.15
52 Week low$23.15
MRNA News
TipRanks 3d
Moderna’s Stock Tumbles Amid Revenue Drop and DelaysModerna ( (MRNA) ) has fallen by -12.90%. Read on to learn why. Moderna’s stock has experienced a significant decline of 12.90% over the past week, reflecting...
Simply Wall St 5d
Moderna (NasdaqGS:MRNA) Expands AI-Ready Collaboration With Benchling For R&D Transformationrecently expanded its collaboration with Benchling, enhancing its digital infrastructure to foster research innovation. Despite this positive development, Moder...
Analyst ratings
66%
of 29 ratingsBuy
20.7%
Hold
65.5%
Sell
13.8%
People also own
Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.